A COMPARATIVE STUDY OF REPAGLINIDE VERSUS GLIMEPIRIDE MONOTHERAPY IN TYPE - 2 DIABETES MELLITUS PATIENT
English

Sudheer K
2015 Journal of Evidence Based Medicine and Healthcare  
Diabetes mellitus refers to a group of common metabolic disorder that share the phenotype of hyperglycaemia. Insulin resistance and abnormal insulin secretion is central to the development of type 2 DM the primary effect is controversial. Present study is a prospective study conducted to evaluate and compare the effect of glimepiride and Repaglinide in patient with type-2 DM attending general medicine between Oct. 2013 to Oct. 2015. Both the drugs have same glycaemic profile and lipid profile
more » ... and lipid profile but there is significant difference in the change in PPBs and HbA1c % but a study with more no of patient is required to evaluate it more effectively.
doi:10.18410/jebmh/2015/1019 fatcat:c2yx6hs4jfec3cxfbslxtcnewm